Sonoma Pharmaceuticals (SNOA) FCF Margin (2017 - 2022)
Sonoma Pharmaceuticals (SNOA) has 3 years of FCF Margin data on record, last reported at 14.74% in Q4 2012.
- For Q4 2012, FCF Margin rose 5868.0% year-over-year to 14.74%; the TTM value through Mar 2013 reached 131.32%, up 16560.0%, while the annual FY2012 figure was 34.27%, 45032.0% up from the prior year.
- FCF Margin reached 14.74% in Q4 2012 per SNOA's latest filing, down from 94.43% in the prior quarter.
- Across five years, FCF Margin topped out at 94.43% in Q3 2012 and bottomed at 690.41% in Q2 2010.
- Average FCF Margin over 3 years is 97.01%, with a median of 28.88% recorded in 2011.
- Peak YoY movement for FCF Margin: skyrocketed 43345bps in 2011, then crashed -2595bps in 2012.
- A 3-year view of FCF Margin shows it stood at 71.03% in 2010, then soared by 38bps to 43.94% in 2011, then soared by 134bps to 14.74% in 2012.
- Per Business Quant database, its latest 3 readings for FCF Margin were 14.74% in Q4 2012, 94.43% in Q3 2012, and 33.18% in Q2 2012.